Unapproved New Drugs
Similar Posts
FDA Responds to Evidence of Possible Association Between Autism and Acetaminophen Use During Pregnancy
The U.S. Food and Drug Administration today initiated the process for a label change for acetaminophen (Tylenol and similar products) to reflect evidence suggesting that the use of acetaminophen by pregnant women may be associated with an increased risk of neurological conditions such as autism andSafe Use Initiative – Current Projects
Part of Safe Use Initiative
(updated)UPDATE – Sandoz Inc. Issues Voluntary Nationwide Recall Expansion of One Additional Lot of Cefazolin for Injection Due to Product Mislabeling
Sandoz, Inc. (“Sandoz”) is initiating a voluntary nationwide recall expansion of one additional lot of Cefazolin for Injection, USP, 1 gram per vial. The lot is being recalled due to a customer complaint indicating that four (4) vials incorrectly labelled as Penicillin G Potassium for Injection, USP2024 Safety Communications
Listing of Medical Device 2024 Safety CommunicationsJoint US FDA – Health Canada ICH Public Meeting – 02/22/2024
Joint US FDA – Health Canada ICH Public MeetingHard Steel contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Hard Steel, a product promoted and sold for sexual enhancement on various websites, including www.hardsteelusa.com and possibly in some retail stores.